fluvirin
novartis vaccines & diagnostics pty ltd - influenza virus haemagglutinin -
menveo
novartis vaccines & diagnostics pty ltd - meningococcal oligosaccharide - group w135; meningococcal oligosaccharide - group c; meningococcal oligosaccharide - group a; diphtheria crm197 protein; meningococcal oligosaccharide - group y -
agrippal
novartis vaccines & diagnostics pty ltd - influenza virus haemagglutinin -
influenza a- h1n1 2009 monovalent vaccine injection, suspension
novartis vaccines and diagnostics ltd - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) (unii: k9p8pva2ug) (influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) - unii:k9p8pva2ug) - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) 15 ug in 0.5 ml - influenza a (h1n1) 2009 monovalent vaccine is an inactivated influenza virus vaccine indicated for immunization of persons 4 years of age and older against influenza disease caused by pandemic (h1n1) 2009 virus. influenza a (h1n1) 2009 monovalent vaccine should not be administered to anyone with known systemic hypersensitivity reactions to egg proteins (eggs or egg products), or to any component of influenza a (h1n1) 2009 monovalent vaccine, or who has had a life-threatening reaction to previous influenza vaccinations [see description (11)]. novartis’ influenza a (h1n1) 2009 monovalent vaccine and seasonal trivalent influenza virus vaccine (fluvirin) are manufactured by the same process. available information for fluvirin is provided in this section. pregnancy category c: animal reproduction studies have not been conducted with influenza a (h1n1) 2009 monovalent vaccine or fluvirin. it is also not known whether influenza a (h1n1) 2009 monovalent vaccine or fluvirin can cause fetal harm when administered to
menveo meningococcal (groups y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine
novartis vaccines and diagnostics s.r.l. - neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen (unii: 3o44u6xyqk) (neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen - unii:3o44u6xyqk) - neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug in 0.5 ml
fluvirin influenza virus a/christchurch/16/2010 nib-74 (h1n1) hemagglutinin antigen (propiolactone inactivated) a/switzerland/97
novartis vaccines and diagnostics limited - influenza a virus a/christchurch/16/2010 nib-74 (h1n1) antigen (propiolactone inactivated) (unii: h41xp0e6g8) (influenza a virus a/christchurch/16/2010 nib-74 (h1n1) hemagglutinin antigen (propiolactone inactivated) - unii:w3d48fdo26) - influenza a virus a/christchurch/16/2010 nib-74 (h1n1) hemagglutinin antigen (propiolactone inactivated) 15 ug in 0.5 ml
fluad influenza virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) a/switzerland/9715293/2013 nib-88 (h3n
novartis vaccines and diagnostics limited - influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) (unii: 872508x6jg) (influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:5cl7878s2q) - influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) 15 ug in 0.5 ml
bexsero neisseria meningitidis serogroup nhba fusion protein antigen fhbp and nada injection suspension
novartis vaccines and diagnostics srl - neisseria meningitidis serogroup b nhba fusion protein antigen (unii: 28e911y7ae) (neisseria meningitidis serogroup b nhba fusion protein antigen - unii:28e911y7ae) - neisseria meningitidis serogroup b nhba fusion protein antigen 50 ug in 0.5 ml
fluad, suspension for injection in pre-filled syringe
novartis vaccines and diagnostics s.r.l. - a/california/7/2009 (h1n1) - derived strain used nymc x-181 reass a/california/7/2009 (h1n1) - derived strain used nymc x-181 reass b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 0.5
agrippal suspension for injection
novartis vaccines and diagnostics s.r.l. - a/california/7/2009 (h1n1) - derived strain used nymc x-181 reass a/california/7/2009 (h1n1) - derived strain used nymc x-181 reass b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection